Found: 1
Select item for more details and to access through your institution.
A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab ( ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.
- Published in:
- Veterinary Dermatology, 2016, v. 27, n. 6, p. 478, doi. 10.1111/vde.12376
- By:
- Publication type:
- Article